Last updated: June 25, 2024
Sponsor: Henan Institute of Cardiovascular Epidemiology
Overall Status: Active - Recruiting
Phase
N/A
Condition
Heart Disease
Thrombosis
Chest Pain
Treatment
DES
DCB
Clinical Study ID
NCT05750771
HenanICE202303
Ages > 60 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- older than 60 years of age.
- meeting the indications for coronary intervention.
- IVUS examination suggests severe calcified lesions (calcification angle > 270°at the target lesion) or OCT examination suggests severe calcified lesions (calcification angle > 180° and/or length > 5 mm and/or thickness > 0.5 mm);
- Target lesion vessel diameter > 2.5 mm
Exclusion
Exclusion Criteria:
- inability to provide written informed consent.
- unable to administer antiplatelet agents and anticoagulant therapy; haveallergies to heparin, contrast agents, etc.
- the subject is participating in another uncompleted clinical trial
- life expectancy <1 year.
- non-in situ vascular lesions.
- cardiogenic shock.
- Patients with hemodynamic instability
Study Design
Total Participants: 200
Treatment Group(s): 2
Primary Treatment: DES
Phase:
Study Start date:
February 20, 2023
Estimated Completion Date:
December 20, 2025
Connect with a study center
Fuwai central China cardiovascular Hospital
Zhengzhou, Henan
ChinaActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.